Evidence Corner
Welcome to Evidence Corner. Here we try to explain the data behind the clinical decisions we make through deep-diving studies that have shaped how we treat patients with liver disease. For each clinical question, we’ve chosen a single study and with our digestible slides, we try to concisely highlight the key aspects of the study.
Series Team
Fellow Lead
Faculty Editor
Evidence CornerWhy do we transfuse to a hemoglobin goal of ≥7g/dL?
Ever wondered why we tell people to transfuse to a goal hemoglobin greater than 7? This is the evidence corner for you!
Lizzie AbyEvidence CornerShould we consider TIPS in patients with decompensated cirrhosis presenting with esophageal variceal bleeding?
In high risk patients that have variceal bleeding, have you ever wondered if there may be a role for therapies other than medicines and endoscopy? This evidence corner helps to answer just that question.
Lizzie AbyEvidence CornerWhy do we give albumin to patients with cirrhosis with spontaneous bacterial peritonitis?
Have you ever wondered why we give albumin to patients with SBP? If so, this is the Evidence Corner for you.
Lizzie AbyEvidence CornerWhy do we (and when should we) give steroids for alcoholic hepatitis?
Alex VogelEvidence CornerWhy do we give antibiotics to patients with cirrhosis with bleeding?
Alex VogelSeries Team
Fellow Lead
Faculty Editor
Ideas?
Do you have suggestions for topics within this series? Are you a fellow interested in contributing? Please feel free to reach out via Twitter to the fellow lead or to Liver Fellow Network directly. You can also e-mail us at liverfellownetwork@gmail.com.